APA

Han K., Peyret T., Quartino A., Gosselin N. H., Gururangan S., Casanova M., Merks J. H. M., Massimino M., Grill J., Daw N. C., Navid F., Jin J. & Allison D. E. (20161005). Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. : British journal of clinical pharmacology.

Chicago

Han Kelong, Peyret Thomas, Quartino Angelica, Gosselin Nathalie H, Gururangan Sridharan, Casanova Michela, Merks Johannes H M, Massimino Maura, Grill Jacques, Daw Najat C, Navid Fariba, Jin Jin and Allison David E. 20161005. Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. : British journal of clinical pharmacology.

Harvard

Han K., Peyret T., Quartino A., Gosselin N. H., Gururangan S., Casanova M., Merks J. H. M., Massimino M., Grill J., Daw N. C., Navid F., Jin J. and Allison D. E. (20161005). Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. : British journal of clinical pharmacology.

MLA

Han Kelong, Peyret Thomas, Quartino Angelica, Gosselin Nathalie H, Gururangan Sridharan, Casanova Michela, Merks Johannes H M, Massimino Maura, Grill Jacques, Daw Najat C, Navid Fariba, Jin Jin and Allison David E. Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. : British journal of clinical pharmacology. 20161005.